Ligand validation:4GWW

F6P: 6-O-phosphono-beta-D-fructofuranose

F6P is a Ligand Of Interest in 4GWW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GWW_F6P_A_402	54%	64%	0.18	0.944	0.6	0.76	-	-	1	0	100%	1
4GWW_F6P_A_401	6%	55%	0.323	0.765	0.95	0.78	1	-	0	0	100%	1
1NUW_F6P_A_2336	98%	59%	0.064	0.987	0.63	0.95	-	1	0	0	100%	1
1CNQ_F6P_A_339	95%	44%	0.077	0.98	0.99	1.17	-	1	0	0	100%	1
1NV3_F6P_A_2339	93%	66%	0.085	0.981	0.55	0.77	-	-	0	0	100%	1
1NUY_F6P_A_2339	93%	59%	0.079	0.974	0.66	0.9	-	1	1	0	100%	0.9375
4GWS_F6P_A_401	92%	53%	0.091	0.98	0.95	0.88	1	-	1	0	100%	1
5HR5_F6P_A_602	99%	59%	0.064	0.991	0.94	0.64	1	-	0	0	100%	1
6HVI_F6P_A_603	97%	53%	0.071	0.986	0.8	1.03	1	1	0	0	100%	1
6IBX_F6P_A_504	93%	47%	0.09	0.987	0.91	1.12	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.